With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer

With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer

Source: 
Xconomy
snippet: 

Some of the targets in cancer research are visible and well known, but they’re hard to hit with new drugs all the same. PIC Therapeutics is developing medicines aiming for one particularly elusive group of proteins, and the startup’s early research has attracted financial support from some prominent names in the life sciences industry.